Patent news news from FiercePharma
NewsGSK sues over new patent rules
Pharma is one of few industries where patent law doesn't inspire a yawn. So when the U.S. Patent Office introduced unfriendly rules governing patent continuations--vital to protecting brand-name... Read more...
King regoups after patent fight loss
Please, please, please change your mind: Yesterday, King Pharmaceuticals lost its fight with Indian generics maker Lupin when a federal appeals court invalidated the patent on Altace. Today, King... Read more...
Roche: Patent ruling won't stop Mircera
Roche has lost turf to Amgen in their patent battle over Mircera, an anti-anemia drug now under FDA review. A federal judge says that yes, the Roche remedy does infringe on an Amgen patent. Amgen's... Read more...
Novartis, Ranbaxy argue over Diovan patent
Meanwhile, Novartis is suing the Indian generics giant Ranbaxy Laboratories over a copycat version of
| Press ReleasesPRESS RELEASE: Canadian Court Favors Ranbaxy, Dismisses Pfizer's Application on Atrovastatin Patent CANADIAN FEDERAL COURT FAVOURS RANBAXY DISMISSES PFIZER'S APPLICATION ON ATORVASTATIN PATENT CA 2,220,455 Gurgaon, Haryana, India, Princeton, New Jersey, USA - September 13, 2007 Ranbaxy Read more >> PRESS RELEASE: Court Rules That Roche Infringes One of Amgen's Erythropoietin Patents Court Rules That Roche Infringes One of Amgen's Erythropoietin Patents THOUSAND OAKS, Calif. -- Aug 28, 2007 - Amgen today announced that the U.S. Federal District Court in Boston granted Amgen's Read more >> |
Get more Patent news coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
